Idexx Laboratories
IDXX
314 hedge funds and large institutions have $6.14B invested in Idexx Laboratories in 2014 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 80 increasing their positions, 129 reducing their positions, and 19 closing their positions.
173% more call options, than puts
Call options by funds: $4.27M | Put options by funds: $1.57M
95% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 19
29% more funds holding in top 10
Funds holding in top 10: 7 → 9 (+2)
12% more capital invested
Capital invested by funds: $5.46B → $6.14B (+$677M)
5% more funds holding
Funds holding: 298 → 314 (+16)
38% less repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 129
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Geneva Capital Management
Milwaukee,
Wisconsin
|
+$33.4M |
| 2 |
CCI
Columbus Circle Investors
|
+$28.2M |
| 3 |
AI
Analytic Investors
Los Angeles,
California
|
+$19M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$17.9M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$16.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair & Company
Chicago,
Illinois
|
-$78.8M |
| 2 |
RA
Royce & Associates
New York
|
-$34.7M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
-$26.4M |
| 4 |
VanEck Associates
New York
|
-$22.9M |
| 5 |
SGA
Sustainable Growth Advisers
Stamford,
Connecticut
|
-$22M |
IDXX Hedge Fund Activity: Q1 2014 in Review
314 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q1 2014, worth a combined $6.14B — up 12% from $5.46B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new IDXX positions and 19 closed out — a net gain of 18 holders — while 80 added to existing stakes and 129 trimmed.
The largest buyer was Geneva Capital Management, opening a new position worth an estimated $33.4M. The largest seller was William Blair & Company, cutting an estimated $78.8M.
- 314 institutional investors held Idexx Laboratories (IDXX) as of Q1 2014, up from 298 in Q4 2013.
- Funds reported $6.14B of Idexx Laboratories stock for Q1 2014, up 12% quarter-over-quarter.
- 37 funds opened new Idexx Laboratories positions in Q1 2014 and 19 closed out, a net change of +18 holders.
- The largest Idexx Laboratories buyer in Q1 2014 was Geneva Capital Management, an estimated $33.4M added.
- The largest Idexx Laboratories seller in Q1 2014 was William Blair & Company, an estimated $78.8M sold.
Based on aggregated 13F filings for Q1 2014.